Biotech

All Articles

Gilead pays J&ampJ $320M to leave licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its own liver disease medicine seladelpar, t...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can easily see the firms setting up tents at basecamp behind Eli Lilly in an effort...

Entero laying off personnel, moving out of workplace as well as pausing R&ampD

.Bed mattress Liquidators has switched Entero Rehabs white as a slab. The lender bought Entero to re...

Exelixis goes down ADC after choosing it is actually no suit for Tivdak

.Exelixis is losing hope on its own tissue aspect (TF)- targeting antibody-drug conjugate after wrap...

Relay loses interest in SHP2 inhibitor after Genentech leaves

.3 full weeks after Roche's Genentech unit bowed out an SHP2 prevention pact, Relay Rehab has confir...

Stoke's Dravet syndrome med launched of partial scientific hold

.Stoke Rehabs' Dravet syndrome medicine has actually been actually freed from a predisposed grip, re...

Fierce Biotech's Gabrielle Masson shows Strong 15 at NYSE

.Intense Biotech Associate Editor Gabrielle Masson provided the 2024 lesson of Fierce 15 winners on ...

Daiichi pays out Merck $170M to form bronchi cancer T-cell engager contract

.Merck &amp Co. has actually rapidly gotten back a number of the costs of its own Harpoon Therapeuti...

BioMarin stops preclinical gene treatment for heart disease

.After BioMarin performed a spring clean of its own pipe in April, the provider has chosen that it a...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks work

.Significant Pharmas stay stuck to the idea of molecular adhesive degraders. The most recent company...